Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
16.1%
% of HELX's 62 holdings also in HRTS
23.1%
% of HRTS's 39 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 5.6% | 5.7% | 5.6% |
|
ELI LILLY & CO | 4.2% | 6.4% | 4.2% |
|
REGENERON PHARMACEUTICALS | 5.3% | 2.4% | 2.4% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% | 2.3% | 2.3% |
|
ROCKET PHARMACEUTICALS, INC. | 2.1% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to HRTS
|
MEDPACE HOLDINGS, INC. | 6.4% |
|
DANAHER CORP | 5.2% |
|
KRYSTAL BIOTECH, INC. | 5.0% |
|
THERMO FISHER SCIENTIFIC INC | 4.9% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 3.3% |
|
NATERA INC | 3.1% |
|
REGENERON PHARMACEUTICALS | 2.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.6% |
|
MODERNA, INC. | 2.5% |
|
BRUKER CORP | 2.4% |
HELX Underweight Relative to HRTS
|
AMGEN INC | -5.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
 |
NOVO NORDISK A/S-B | -3.6% |
|
CYTOKINETICS INC | -3.3% |
|
ALNYLAM PHARMACEUTICALS INC | -3.2% |
|
ASTRAZENECA PLC | -3.1% |
|
BOSTON SCIENTIFIC CORP | -3.1% |
|
ASCENDIS PHARMA A/S | -3.1% |
 |
MEDTRONIC PLC | -3.0% |